the success of ibrutinib in treating mantle cell lymphoma (mcl)
Published 8 years ago • 367 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:33
developing mantle cell lymphoma treatment for further success
-
2:35
ash 2014: ibrutinib therapy in mantle cell lymphoma (mcl)
-
2:42
the role of ibrutinib in dlbcl and the value of next-generation btk inhibitors
-
1:21
ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed mcl
-
2:29
ibrutinib maintenance in mcl
-
3:01
treating indolent and mantle cell lymphoma: results of the bright 5 year follow up study
-
0:48
real-world results in the uk for ibrutinib at first relapsed for mcl
-
4:43
how to manage relapsed/refractory mcl - new agents and unmet needs
-
1:01:29
scientist stories: ping chih ho, immunometabolic editing & tumor metabolic evolution
-
2:43
nanoparticle drug delivery in cancer therapy
-
7:59
50 years of ebmt | per ljungman — ebmt's roles & strategies in virus and pandemic management
-
2:23
zilo-301: phase iii study of zilovertamab ibrutinib vs ibrutinib in r/r mcl
-
1:56
ibrutinib treatment and its associated risk factors
-
1:29
insights into the uses of ibrutinib for patients with waldenström’s macroglobulinemia
-
1:31
new therapies for mantle cell lymphoma
-
2:07
efficacy of ibrutinib in the treatment of cll patients with del(17p) and tp53 mutation
-
2:39
the safety and efficacy of ibrutinib for the treatment of cll
-
0:55
zanubrutinib in mantle cell lymphoma: updated safety and efficacy data
-
9:02
martin dreyling, md: efficacy of first-line ibrutinib in mcl
-
1:38
the uk treatment landscape of mantle cell lymphoma
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
2:00
ibrutinib in mantle cell lymphoma - an update